Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03475147 · ClinicalTrials.gov registry record · NA
Smartphone Flicker Fusion Test for Patients With Optic Disorders.
A NA study of Scotoma, sponsored by Randy Kardon.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT03475147 is a NA study of Scotoma that is actively recruiting participants, run by Randy Kardon. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03475147, a NA study of Scotoma, is actively recruiting participants, sponsored by Randy Kardon.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to validate a quick, easy-to-use and administer smartphone flicker fusion test. The app (called eyeFusion) can potentially be used to easily and quickly collect critical flicker fusion measurements on patients admitted with optic disorders as part of the clinical care process.
Conditions Studied
Interventions
- DEVICE eyeFusion
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-01-27 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03475147
The ClinicalTrials.gov registry entry for NCT03475147 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Randy Kardon, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Scotoma appearing as the primary indexed condition, and to 1 intervention - of which eyeFusion is the first listed.
NCT03475147 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT03475147 about?
NCT03475147 is a clinical study titled "Smartphone Flicker Fusion Test for Patients With Optic Disorders.". The purpose of this project is to validate a quick, easy-to-use and administer smartphone flicker fusion test. The app (called eyeFusion) can potentially be used to easily and quickly collect critical flicker fusion measurements on patients admitted with optic disorders as part of the clinical care ...
What is the current status of trial NCT03475147?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2017-01-27. Estimated completion is 2028-01-01.
What conditions does trial NCT03475147 study?
This clinical trial studies the following conditions: Scotoma.
What interventions are being tested in trial NCT03475147?
The interventions under investigation include: eyeFusion (DEVICE).
Who is sponsoring clinical trial NCT03475147?
This trial is sponsored by Randy Kardon, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03475147 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.